HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of saccharomyces boulardii with antibiotics in acute amoebiasis.

AbstractAIM:
To compare the efficacy of antibiotics therapy alone with antibiotics and saccharomyces boulardii in treatment of acute amebiasis.
METHODS:
In a double blind, random clinical trial on patients with acute intestinal amoebiasis, 57 adult patients with acute amoebiasis, diagnosed with clinical manifestations (acute mucous bloody diarrhea) and amebic trophozoites engulfing RBCs found in stool were enrolled in the study. Regimen 1 included metronidazole (750 mg Tid) and iodoquinol (630 mg Tid) for 10 days. Regimen 2 contained capsules of lyophilized saccharomyces boulardii (250 mg Tid) orally in addition to regimen 1. Patients were re-examined at two and four weeks after the treatment, and stool examination was performed at the end of week 4. Student's t-test, chi(2) and McNemar's tests were used for statistical analysis.
RESULTS:
Three patients refused to participate. The other 54 patients were randomized to receive either regimen 1 or regimen 2 (Groups 1 and 2 respectively, each with 27 patients). The two groups were similar regarding their age, sex and clinical manifestations. In Group 1, diarrhea lasted 48.0+/-18.5 hours and in Group 2, 12.0+/-3.7 hours (P<0.0001). In Group 1, the durations of fever and abdominal pain were 24.0+/-8.8 and 24.0+/-7.3 hours and in Group 2 they were 12.0+/-5.3 and 12.0+/-3.2 hours, respectively (P<0.001). Duration of headache was similar in both groups. At week 4, amebic cysts were detected in 5 cases (18.5 %) of Group 1 but in none of the Group 2 (P<0.02).
CONCLUSION:
Adding saccharomyces boulardii to antibiotics in the treatment of acute amebiasis seems to decrease the duration of clinical symptoms and cyst passage.
AuthorsFariborz Mansour-Ghanaei, Najaf Dehbashi, Kamyar Yazdanparast, Afshin Shafaghi
JournalWorld journal of gastroenterology (World J Gastroenterol) Vol. 9 Issue 8 Pg. 1832-3 (Aug 2003) ISSN: 1007-9327 [Print] United States
PMID12918131 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Amebicides
  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Capsules
  • Metronidazole
  • Iodoquinol
Topics
  • Acute Disease
  • Administration, Oral
  • Amebiasis (therapy)
  • Amebicides (therapeutic use)
  • Anti-Bacterial Agents
  • Anti-Infective Agents (therapeutic use)
  • Capsules
  • Double-Blind Method
  • Drug Therapy, Combination (therapeutic use)
  • Humans
  • Iodoquinol (therapeutic use)
  • Metronidazole (therapeutic use)
  • Probiotics (administration & dosage)
  • Saccharomyces
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: